✦ LIBER ✦

PA77 VIROLOGICAL RESPONSE TO COMBINATION THERAPY WITH LAMIVUDINE AND TENOFOVIR IN A LIVER TRANSPLANTED GIRL WITH DE NOVO HEPATITIS B VIRUS INFECTION

✍ Scribed by M. Tufano; C. Della Corte; G. Ranucci; M. Candusso; G. Torre; R. Iorio

Book ID: 119634261
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 73 KB
Volume: 42
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(10)60671-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of combined antiviral therapy w

Efficacy of combined antiviral therapy with lamivudine and tenofovir in a liver transplanted girl with de novo hepatitis B virus infection

✍ Tufano, M.; Liccardo, D.; Riva, S.; Candusso, M.; Torre, G.; Iorio, R. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Impact on liver histology and relationsh

Impact on liver histology and relationship with response to combination therapy of occult hepatitis B virus infection in patients with chronic hepatitis C

✍ P. Fabris; D. Brown; G. Tositti; L. Bozzola; M.T. Giordani; P. Bevilacqua; F. de 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 165 KB

(160) Predictors of responses to adefovi

(160) Predictors of responses to adefovir therapy in patients with lamivudine-resistant hepatitis B virus YMDD mutant before and after liver transplantation

✍ Ahmed Helmy; Ayman. Abdo; Hatim Mudawi; Khalid Al-Kahtani; Hamad Al-Ashgar; Moha 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 41 KB

Adefovir and lamivudine in combination c

Adefovir and lamivudine in combination compared with adefovir monotherapy in HBeAg-negative adults with chronic hepatitis B virus infection and clinical or virologic resistance to lamivudine: A retrospective, multicenter, nonrandomized, open-label study

✍ Adriano M. Pellicelli; Giuseppe Barbaro; Ruggiero Francavilla; Mario Romano; Gio 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 536 KB

Prediction of sustained virological resp

Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing

✍ Guy W. Neff; Christopher B. O'Brien; Robert Cirocco; Marzia Montalbano; Maria de 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 2 views

The optimal duration of therapy for pegylated interferon combined with ribavirin in recurrent Hepatitis C virus (HCV) following liver transplantation is not known. We wanted to determine if testing for HCV in liver tissue by reverse transcriptase polymerase chain reaction (RT-PCR) was superior in pr

Mutations in the protein kinase-binding

Mutations in the protein kinase-binding domain of the nonstructural 5A protein and sustained virological response to combination therapy in patients chronically infected with hepatitis C virus type-1B

✍ H. Akkiz; Y. Ergun; S. Colakoglu; M. Sandikci; M. Serin; A. Bekar; M. Oksuz; F.Y 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 165 KB